SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia293Stable, ...
This partnership provides the industry with cutting-edge options for mammalian-expressed products. OKLAHOMA CITY & MONTHEY, Switzerland--(BUSINESS WIRE)--ExcellGene SA, a leading Swiss biotech service ...
Making proteins for research or therapies often starts with cell-line development. In many applications, genetic engineering is used to optimize a cell line for producing high levels of the intended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback